Mina Nakauchi

Dr. Mina Nakauchi

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2009 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
IIItoe Iizuka
Itoe Iizuka
MSMasayuki Saijo
Masayuki Saijo
TSTomoyuki Shiota
Tomoyuki Shiota
YAYasushi Ami
Yasushi Ami
YSYuriko Suzaki
Yuriko Suzaki
SMShigeru Morikawa
Shigeru Morikawa

1 January 2010 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
HLHyun-Kyoung Lee
Hyun-Kyoung Lee
BLByoung-Hee Lee
Byoung-Hee Lee
SSSeung Hyeok Seok
Seung Hyeok Seok
MBMin-Won Baek
Min-Won Baek
HLHui-Young Lee
Hui-Young Lee
JPJae-Hak Park
Jae-Hak Park
Lee HK, et al. J Vet Sci. 2010 Jun;11(2):165-167. http://dx.doi.org/10.4142/jvs.2010.11.2.165

1 November 2014 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
YMYoko Matsuzaki
Yoko Matsuzaki
KSKanetsu Sugawara
Kanetsu Sugawara
MNMina Nakauchi
Mina Nakauchi
YTYoshimasa Takahashi
Yoshimasa Takahashi
TOTaishi Onodera
Taishi Onodera
ENEri Nobusawa
Eri Nobusawa
We determined the antigenic structure of pandemic influenza A(H1N1)pdm09 virus hemagglutinin (HA) using 599 escape mutants that were selected using 16 anti-HA monoclonal antibodies (MAbs) against A/Narita/1/2009. The sequencing of mutant HA genes revealed 43 amino acid substitutions at 24 positions in three antigenic sites, Sa, Sb, and Ca2, which were previously mapped onto A/Puerto Rico/8/34 (A/PR/8/34) HA (A. J. Caton, G. G. Brownlee, J. W. Yewdell, and W. Gerhard, Cell 31:417–427, 1982), and an undesignated site, i.e., amino acid residues 141, 142, 143, 171, 172, 174, 177, and 180 in the Sa site, residues 170, 173, 202, 206, 210, 211, and 212 in the Sb site, residues 151, 154, 156, 157, 158, 159, 200, and 238 in the Ca2 site, and residue 147 in the undesignated site (numbering begins at the first methionine). Sixteen MAbs were classified into four groups based on their cross-reactivity with the panel of escape mutants in the hemagglutination inhibition test. Among them, six MAbs targeting the Sa and Sb sites recognized both residues at positions 172 and 173. MAb n2 lost reactivity when mutations were introduced at positions 147, 159 (site Ca2), 170 (site Sb), and 172 (site Sa). We designated the site consisting of these residues as site Pa. From 2009 to 2013, no antigenic drift was detected for the A(H1N1)pdm09 viruses. However, if a novel variant carrying a mutation at a position involved in the epitopes of several MAbs, such as 172, appeared, such a virus would have the advantage of becoming a drift strain. IMPORTANCE The first influenza pandemic of the 21st century occurred in 2009 with the emergence of a novel virus originating with swine influenza, A(H1N1)pdm09. Although HA of A(H1N1)pdm09 has a common origin (1918 H1N1) with seasonal H1N1, the antigenic divergence of HA between the seasonal H1N1 and A(H1N1)pdm09 viruses gave rise to the influenza pandemic in 2009. To take precautions against the antigenic drift of the A(H1N1)pdm09 virus in the near future, it is important to identify its precise antigenic structure. To obtain various mutants that are not neutralized by MAbs, it is important to neutralize several plaque-cloned parent viruses rather than only a single parent virus. We characterized 599 escape mutants that were obtained by neutralizing four parent viruses of A(H1N1)pdm09 in the presence of 16 MAbs. Consequently, we were able to determine the details of the antigenic structure of HA, including a novel epitope.

1 January 2011 in Journal of Virological Methods
Verified
Journal Article
Closed access
MNMina Nakauchi
Mina Nakauchi
YYYoshihiro Yasui
Yoshihiro Yasui
TMTatsuya Miyoshi
Tatsuya Miyoshi
HMHiroko Minagawa
Hiroko Minagawa
TTTomoyuki Tanaka
Tomoyuki Tanaka
TKTsutomu Kageyama
Tsutomu Kageyama

1 May 2019 in Journal of Virological Methods
Verified
Journal Article
Open access
ITIkuyo Takayama
Ikuyo Takayama
MNMina Nakauchi
Mina Nakauchi
HTHitoshi Takahashi
Hitoshi Takahashi
KOKunihiro Oba
Kunihiro Oba
SSShohei Semba
Shohei Semba
TKTsutomu Kageyama
Tsutomu Kageyama
Influenza virus and respiratory syncytial virus cause acute upper and lower respiratory tract infections, especially in children and the elderly. Early treatment for these infections is thought to be important, so simple and sensitive detection methods are needed for use at clinical sites. Therefore, in this study, real-time reverse transcription loop-mediated isothermal amplification assays with quenching primer for influenza virus and respiratory syncytial virus were developed. Evaluation of a total of 113 clinical specimens compared to real-time RT-PCR assays showed that the novel assays could distinguish between the types and subtypes of influenza virus and respiratory syncytial virus and had 100% diagnostic specificity. The diagnostic sensitivity of each assay exceeded 85.0% and the assays showed sufficient clinical accuracy. Furthermore, positive results could be obtained in around 15 min using the novel assays in cases with high concentrations of virus. The developed assays should be useful for identifying influenza virus and respiratory syncytial virus cases not only in experimental laboratories but also in hospital and quarantine laboratories.

24 November 2010 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MNMina Nakauchi
Mina Nakauchi
TYTetsushi Yoshikawa
Tetsushi Yoshikawa
HNHidetaka Nakai
Hidetaka Nakai
KSKen Sugata
Ken Sugata
AYAkiko Yoshikawa
Akiko Yoshikawa
TKTsutomu Kageyama
Tsutomu Kageyama